|
1
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14(Suppl 5): v1–v49. 2012.PubMed/NCBI
|
|
2
|
Gauden AJ, Hunn A, Erasmus A, Waites P,
Dubey A and Gauden SJ: Combined modality treatment of newly
diagnosed glioblastoma multiforme in a regional neurosurgical
centre. J Clin Neurosci. 16:1174–1179. 2009. View Article : Google Scholar
|
|
3
|
Jansen M, Yip S and Louis DN: Molecular
pathology in adult gliomas: diagnostic, prognostic, and predictive
markers. Lancet Neurol. 9:717–726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arora S, Singh S, Piazza GA, Contreras CM,
Panyam J and Singh AP: Honokiol: a novel natural agent for cancer
prevention and therapy. Curr Mol Med. 12:1244–1252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ishikawa C, Arbiser JL and Mori N:
Honokiol induces cell cycle arrest and apoptosis via inhibition of
survival signals in adult T-cell leukemia. Biochim Biophys Acta.
1820:879–887. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang T, Chen F, Chen Z, Wu YF, Xu XL,
Zheng S and Hu X: Honokiol induces apoptosis through
p53-independent pathway in human colorectal cell line RKO. World J
Gastroenterol. 10:2205–2208. 2004.PubMed/NCBI
|
|
7
|
Arora S, Bhardwaj A, Srivastava SK, Singh
S, McClellan S, Wang B and Singh AP: Honokiol arrests cell cycle,
induces apoptosis, and potentiates the cytotoxic effect of
gemcitabine in human pancreatic cancer cells. PLoS One.
6:e215732011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wolf I, O’Kelly J, Wakimoto N, et al:
Honokiol, a natural biphenyl, inhibits in vitro and in
vivo growth of breast cancer through induction of apoptosis and
cell cycle arrest. Int J Oncol. 30:1529–1537. 2007.
|
|
9
|
Hahm ER and Singh SV: Honokiol causes
G0–G1 phase cell cycle arrest in human
prostate cancer cells in association with suppression of
retinoblastoma protein level/phosphorylation and inhibition of E2F1
transcriptional activity. Mol Cancer Ther. 6:2686–2695. 2007.
|
|
10
|
Wang Y, Yang Z and Zhao X: Honokiol
induces paraptosis and apoptosis and exhibits schedule-dependent
synergy in combination with imatinib in human leukemia cells.
Toxicol Mech Methods. 20:234–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaushik G, Ramalingam S, Subramaniam D, et
al: Honokiol induces cytotoxic and cytostatic effects in malignant
melanoma cancer cells. Am J Surg. 204:868–873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Duan X, Yang G, et al: Honokiol
crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L
intracerebral gliosarcoma model and human U251 xenograft glioma
model. PLoS One. 6:e184902011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jeong JJ, Lee JH, Chang KC and Kim HJ:
Honokiol exerts an anticancer effect in T98G human glioblastoma
cells through the induction of apoptosis and the regulation of
adhesion molecules. Int J Oncol. 41:1358–1364. 2012.
|
|
14
|
Ren X, Zhang Y, Li C, et al: Enhancement
of baicalin by hexamethylene bisacetamide on the induction of
apoptosis contributes to simultaneous activation of the intrinsic
and extrinsic apoptotic pathways in human leukemia cells. Oncol
Rep. 30:2071–2080. 2013.
|
|
15
|
Liu J, Bi G, Wen P, et al: Down-regulation
of CD44 contributes to the differentiation of HL-60 cells induced
by ATRA or HMBA. Cell Mol Immunol. 4:59–63. 2007.PubMed/NCBI
|
|
16
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–907. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shimizu S, Narita M and Tsujimoto Y: Bcl-2
family proteins regulate the release of apoptogenic cytochrome
c by the mitochondrial channel VDAC. Nature. 399:483–487.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishitsuka K, Hideshima T, Hamasaki M, et
al: Honokiol overcomes conventional drug resistance in human
multiple myeloma by induction of caspase-dependent and -independent
apoptosis. Blood. 106:1794–1800. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rahaman SO, Harbor PC, Chernova O, Barnett
GH, Vogelbaum MA and Haque SJ: Inhibition of constitutively active
Stat3 suppresses proliferation and induces apoptosis in
glioblastoma multiforme cells. Oncogene. 21:8404–8413. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu H and Jove R: The STATs of cancer - new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou J, Bi C, Janakakumara JV, et al:
Enhanced activation of STAT pathways and overexpression of survivin
confer resistance to FLT3 inhibitors and could be therapeutic
targets in AML. Blood. 113:4052–4062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohtsubo M, Theodoras AM, Schumacher J,
Roberts JM and Pagano M: Human cyclin E, a nuclear protein
essential for the G1-to-S phase transition. Mol Cell Biol.
15:2612–2624. 1995.PubMed/NCBI
|
|
23
|
Ullah Z, Lee CY and Depamphilis ML:
Cip/Kip cyclin-dependent protein kinase inhibitors and the road to
polyploidy. Cell Div. 4:102009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Constantinou C, Papas KA and Constantinou
AI: Caspase-independent pathways of programmed cell death: the
unraveling of new targets of cancer therapy? Curr Cancer Drug
Targets. 9:717–728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Battle TE, Arbiser J and Frank DA: The
natural product honokiol induces caspase-dependent apoptosis in
B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood.
106:690–697. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Desagher S and Martinou JC: Mitochondria
as the central control point of apoptosis. Trends Cell Biol.
10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reed JC, Jurgensmeier JM and Matsuyama S:
Bcl-2 family proteins and mitochondria. Biochim Biophys Acta.
1366:127–137. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ramos S: Cancer chemoprevention and
chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr
Food Res. 52:507–526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang W and Liu HT: MAPK signal pathways
in the regulation of cell proliferation in mammalian cells. Cell
Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Glassmann A, Reichmann K, Scheffler B,
Glas M, Veit N and Probstmeier R: Pharmacological targeting of the
constitutively activated MEK/MAPK-dependent signaling pathway in
glioma cells inhibits cell proliferation and migration. Int J
Oncol. 39:1567–1575. 2011.PubMed/NCBI
|
|
31
|
Kyriakis JM and Avruch J: Mammalian
mitogen-activated protein kinase signal transduction pathways
activated by stress and inflammation. Physiol Rev. 81:807–869.
2001.PubMed/NCBI
|
|
32
|
Qiao S, Murakami K, Zhao Q, et al:
Mimosine-induced apoptosis in C6 glioma cells requires the release
of mitochondria-derived reactive oxygen species and p38, JNK
activation. Neurochem Res. 37:417–427. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sharma V, Koul N, Joseph C, Dixit D, Ghosh
S and Sen E: HDAC inhibitor, scriptaid, induces glioma cell
apoptosis through JNK activation and inhibits telomerase activity.
J Cell Mol Med. 14:2151–2161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huh JE, Kang KS, Chae C, Kim HM, Ahn KS
and Kim SH: Roles of p38 and JNK mitogen-activated protein kinase
pathways during cantharidin-induced apoptosis in U937 cells.
Biochem Pharmacol. 67:1811–1818. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Konopleva M, Contractor R, Kurinna SM,
Chen W, Andreeff M and Ruvolo PP: The novel triterpenoid CDDO-Me
suppresses MAPK pathways and promotes p38 activation in acute
myeloid leukemia cells. Leukemia. 19:1350–1354. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han LL, Xie LP, Li LH, Zhang XW, Zhang RQ
and Wang HZ: Reactive oxygen species production and Bax/Bcl-2
regulation in honokiol-induced apoptosis in human hepatocellular
carcinoma SMMC-7721 cells. Environ Toxicol Pharmacol. 28:97–103.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stearns D, Chaudhry A, Abel TW, Burger PC,
Dang CV and Eberhart CG: c-myc overexpression causes anaplasia in
medulloblastoma. Cancer Res. 66:673–681. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gu J, Li G, Sun T, et al: Blockage of the
STAT3 signaling pathway with a decoy oligonucleotide suppresses
growth of human malignant glioma cells. J Neurooncol. 89:9–17.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rajendran P, Li F, Shanmugam MK, et al:
Honokiol inhibits signal transducer and activator of
transcription-3 signaling, proliferation, and survival of
hepatocellular carcinoma cells via the protein tyrosine phosphatase
SHP-1. J Cell Physiol. 227:2184–2195. 2012. View Article : Google Scholar
|
